BIOAFFINITY TECHNOLOGIES INC (BIAF)

US09076W1099 - Common Stock

2.45  +0.57 (+30.32%)

Premarket: 2.52 +0.07 (+2.86%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-7.94M-8.15M-6.33M-7.27M
Depreciation Amortization
249.59K10.00K0.0020.00K
Change In Working Capital
900.79K110.00K630.00K480.00K
Interest Paid
37.13K30.00KN/AN/A
Taxes Paid
20.99K0.000.000.00
Other non cash items
748.82K3.96M3.64M4.56M
OPERATING CASH FLOW
-6.04M-4.07M-2.05M-2.21M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-22.90K-220.00K0.000.00
Other Investing Activity
-2.19MN/AN/AN/A
INVESTING CASH FLOW
-2.21M-220.00K0.000.00
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-344.98K580.00K3.51M1.72M
Stock Issued/Repurchased
N/A13.82MN/AN/A
Other Financing Activity
N/A-60.00K-180.00K0.00
FINANCING CASH FLOW
-344.98K14.34M3.33M1.72M
 
CHANGE IN CASH
-8.59M10.05M1.28M-490.00K
 
FREE CASH FLOW
Operating Cash Flow
-6.04M-4.07M-2.05M-2.21M
Capital Expenditure
-22.90K-220.00K0.000.00
FREE CASH FLOW
-6.06M-4.29M-2.05M-2.21M

All data in USD

Charts